These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 8200414)
1. Involvement of glutamate receptors in the striatal enkephalin-induced dopamine release. Dourmap N; Costentin J Eur J Pharmacol; 1994 Mar; 253(3):R9-11. PubMed ID: 8200414 [TBL] [Abstract][Full Text] [Related]
2. Intrastriatal infusion of (+/-)-S-nitroso-N-acetylpenicillamine releases vesicular dopamine via an ionotropic glutamate receptor-mediated mechanism: an in vivo microdialysis study in chloral hydrate-anesthetized rats. West AR; Galloway MP J Neurochem; 1996 May; 66(5):1971-80. PubMed ID: 8780025 [TBL] [Abstract][Full Text] [Related]
3. Mediation of ionotropic glutamate receptors in domoic acid-induced striatal dopamine release in rats. Quintela BA; Durán R; Alfonso M Eur J Pharmacol; 2000 Aug; 401(2):173-7. PubMed ID: 10924923 [TBL] [Abstract][Full Text] [Related]
4. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. Devine DP; Leone P; Pocock D; Wise RA J Pharmacol Exp Ther; 1993 Sep; 266(3):1236-46. PubMed ID: 7690399 [TBL] [Abstract][Full Text] [Related]
5. Involvement of corticostriatal glutamatergic terminals in striatal dopamine release elicited by stimulation of delta-opioid receptors. Billet F; Dourmap N; Costentin J Eur J Neurosci; 2004 Nov; 20(10):2629-38. PubMed ID: 15548206 [TBL] [Abstract][Full Text] [Related]
6. Depression of potassium-evoked striatal acetylcholine release by delta-receptor activation: inhibition by cholinoactive agents. Ruzicka BB; Jhamandas K Can J Physiol Pharmacol; 1988 Dec; 66(12):1487-92. PubMed ID: 2852536 [TBL] [Abstract][Full Text] [Related]
7. The intrathecal administration of excitatory amino acid receptor antagonists selectively attenuated carrageenan-induced behavioral hyperalgesia in rats. Ren K; Williams GM; Hylden JL; Ruda MA; Dubner R Eur J Pharmacol; 1992 Aug; 219(2):235-43. PubMed ID: 1358641 [TBL] [Abstract][Full Text] [Related]
8. Influence of glial cells in the dopamine releasing effect resulting from the stimulation of striatal delta-opioid receptors. Billet F; Costentin J; Dourmap N Neuroscience; 2007 Nov; 150(1):131-43. PubMed ID: 17942234 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological evidence for N-methyl-D-aspartate receptors on nigrostriatal dopaminergic nerve terminals. Johnson KM; Jeng YJ Can J Physiol Pharmacol; 1991 Oct; 69(10):1416-21. PubMed ID: 1685693 [TBL] [Abstract][Full Text] [Related]
10. Dissociation of mu and delta opioid receptor-mediated reductions in evoked and spontaneous synaptic inhibition in the rat hippocampus in vitro. Lupica CR; Proctor WR; Dunwiddie TV Brain Res; 1992 Oct; 593(2):226-38. PubMed ID: 1360320 [TBL] [Abstract][Full Text] [Related]
11. Presynaptic ionotropic glutamate receptors modulate in vivo release and metabolism of striatal dopamine, noradrenaline, and 5-hydroxytryptamine: involvement of both NMDA and AMPA/kainate subtypes. Ohta K; Araki N; Shibata M; Komatsumoto S; Shimazu K; Fukuuchi Y Neurosci Res; 1994 Nov; 21(1):83-9. PubMed ID: 7535906 [TBL] [Abstract][Full Text] [Related]
12. Role of ionotropic glutamatergic receptors and nitric oxide in the effects of flutriafol, a triazole fungicide, on the in vivo striatal dopamine release. Faro LR; Alfonso M; Maués LA; Durán R J Toxicol Sci; 2012; 37(6):1135-42. PubMed ID: 23208429 [TBL] [Abstract][Full Text] [Related]
13. Involvement of cholinergic neurons in the release of dopamine elicited by stimulation of mu-opioid receptors in striatum. Dourmap N; Clero E; Costentin J Brain Res; 1997 Feb; 749(2):295-300. PubMed ID: 9138730 [TBL] [Abstract][Full Text] [Related]
14. Effect of antagonism of the NMDA receptor on tolerance to [D-Pen2,D-Pen5]enkephalin, a delta 1-opioid receptor agonist. Zhao GM; Bhargava HN Peptides; 1996; 17(2):233-36. PubMed ID: 8801526 [TBL] [Abstract][Full Text] [Related]
15. Involvement of glutamate neurotransmission and N-methyl-d-aspartate receptor in the activation of midbrain dopamine neurons by 5-HT1A receptor agonists: an electrophysiological study in the rat. Gronier B Neuroscience; 2008 Oct; 156(4):995-1004. PubMed ID: 18801415 [TBL] [Abstract][Full Text] [Related]
16. Synergistic activity between the delta-opioid agonist SNC80 and amphetamine occurs via a glutamatergic NMDA-receptor dependent mechanism. Bosse KE; Jutkiewicz EM; Schultz-Kuszak KN; Mabrouk OS; Kennedy RT; Gnegy ME; Traynor JR Neuropharmacology; 2014 Feb; 77():19-27. PubMed ID: 24035916 [TBL] [Abstract][Full Text] [Related]
17. Differential effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid and N-methyl-D-aspartate receptor antagonists applied to the basal forebrain on cortical acetylcholine release and electroencephalogram desynchronization. Rasmusson DD; Szerb IC; Jordan JL Neuroscience; 1996 May; 72(2):419-27. PubMed ID: 8737412 [TBL] [Abstract][Full Text] [Related]
18. Effects of NMDA receptor antagonists on delta1- and delta2-opioid receptor agonists-induced changes in the mouse brain [3H]DPDPE binding. Cao YJ; Bian JT; Bhargava HN Eur J Pharmacol; 1997 Sep; 335(2-3):161-6. PubMed ID: 9369369 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the mechanisms underlying the kainate-induced impairment of [3H]dopamine release in the rat striatum. Fedele E; Versace P; Raiteri M Eur J Pharmacol; 1993 Nov; 249(1):71-7. PubMed ID: 7506667 [TBL] [Abstract][Full Text] [Related]
20. Modulation by muscarine and opioid receptors of acetylcholine release in slices from striato-striatal grafts in the rat. Wichmann T; Starke K Brain Res; 1990 Mar; 510(2):296-302. PubMed ID: 2158852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]